课题基金 / 基金详情

项目摘要

项目成果

Terez Shea-Donohue的其他基金

相似基金

相关文献

中文摘要
翻译
描述(申请人提供):宿主防御的进化以对抗多种病原体为特征,部分特征是朝着Th1或Th2细胞因子分布的极化。众所周知,病原体诱导的Th1和Th2细胞因子的上调会导致肠道平滑肌和上皮细胞反应的刻板甚至相反的变化,而这些反应对宿主的抵抗是重要的。Th1/Th2细胞因子的失衡和Th1细胞因子的过度表达与肠道功能失调有关,是包括炎症性肠病(IBD)在内的许多肠道粘膜炎症状态的特征。我们研究的长期目标是了解特定细胞因子谱的上调如何影响肠道功能,并有助于宿主对肠道病原体的抵抗。在之前的授权期中,我们确定:1)线虫诱导Th2细胞因子上调诱导对宿主抵抗至关重要的依赖STAT6的平滑肌和上皮细胞反应;2)IL-4和IL-13能够与结构细胞上的受体结合并激活STAT6信号通路;3)激活STAT6信号导致影响功能的基因上调;以及4)细胞因子受体在小肠和结肠中的表达不同,并因感染而改变。我们还发现Th1细胞因子对平滑肌的作用依赖于STAT4,而Th2细胞因子诱导的作用与此相反。此外,先前的线虫感染提供了对结肠炎的免疫中介保护,同时改善了结肠功能。我们的初步数据使我们在这项提案中的努力集中在肠道感染改变肠道功能的具体机制上。拟议的研究包含三个特定的目标,旨在检验以下两个中心假设:1)感染诱导的肠道功能变化的发育和持续时间是由细胞因子对结构细胞以及结构和免疫细胞之间的相互作用所介导的(特定目标1和2);以及2)IL-17细胞因子家族的成员在调节与Th1或Th2相关的功能效应中起重要作用(特定目标3)。建议的方法将使用感染自然啮齿动物病原体的小鼠,在体内和体外研究粘膜和平滑肌功能,免疫细胞的原代培养,以及分子和免疫组织化学分析。这些研究将帮助我们理解寄主如何利用生理机制来防御病原体,从而产生促进驱逐的刻板印象功能反应。这些研究的影响是显而易见的,这些功能变化的失调显著损害了寄主的抵抗力,并维持了足够的屏障功能和营养吸收。这些研究还将提供有关线虫感染预防自身免疫性疾病发展的机制,其中许多疾病的特点是肠道屏障功能受损。 项目说明IBD患病率的上升反映在蠕虫感染发病率的下降上,这表明这些疾病的流行病学之间存在一定的关系,部分是基于Th细胞反应的极性。由于免疫系统的主要调节机制之一是控制细胞因子的平衡,因此肠道感染和IBD都被认为是免疫调节治疗的良好靶点。一些线虫诱导Th2细胞因子的升高,包括IL-4和IL-13,这与抵御蠕虫感染的保护性免疫有关。虽然目前IBD的治疗目标是降低Th1细胞因子的活性,但另一种方法是通过增加Th2细胞因子来纠正Th1/Th2细胞因子失衡。最近针对Th2细胞因子的治疗的临床成功为IBD的治疗提供了比标准抗炎和抗免疫方案更特异的治疗方法。感染诱导的Th2和Th1细胞因子的上调对肠道功能有重大影响,而肠道功能是宿主抵抗的重要因素。拟议的研究的意义在于,它们解决了免疫细胞和结构细胞如何相互作用来调节肠道功能。这些研究的影响是基于确定与Th1或Th2反应失调相关的病理相关的潜在治疗靶点。
英文摘要
DESCRIPTION (provided by applicant): The evolution of host defense to combat a multitude of pathogens is characterized, in part, by polarization towards either the Th1 or Th2 cytokine profile. It is known that pathogen-induced up-regulation of Th1 versus Th2 cytokines induces stereotypic and sometimes opposing changes in gut smooth muscle and epithelial cell responses that are important for host resistance. The imbalance of Th1/Th2 cytokines, with over-expression of Th1 cytokines, is associated with dysregulated gut function and is a characteristic of a number of mucosal inflammatory conditions of the gut including inflammatory bowel disease (IBD). The long term objective of our studies is to understand how up-regulation of specific cytokine profiles impacts gut function and contributes to host resistance against enteric pathogens. In the previous grant period we determined that 1) nematode- induced up-regulation of Th2 cytokines induced stereotypic STAT6-dependent changes in smooth muscle and epithelial cell responses that were important for host resistance; 2) IL-4 and IL-13, were able to bind to receptors on structural cells and activate STAT6 signaling pathways; 3) activation of STAT6 signaling resulted in up-regulation of genes that affect function; and 4) cytokine receptor expression was different in the small intestine and colon and is altered by infection. We also showed that the Th1 cytokines exert STAT4- dependent effects on smooth muscle that were opposite to those induced by Th2 cytokines. Moreover, prior nematode infection provided an immune-mediated protection against colitis along with improved colonic function. Our preliminary data led us to focus our efforts in this proposal on the specific mechanisms by which enteric infection alters gut function. The proposed studies contain 3 specific aims that are designed to test the following two central hypotheses: 1) infection-induced development and duration of changes in gut function are mediated by direct effects of cytokines on structural cells and on the interaction between structural and immune cells (Specific Aims 1 and 2); and 2) members of the IL-17 cytokine family are important in regulation of the functional effects associated with the Th1 or Th2 profiles (Specific Aim 3). The proposed approach will use mice infected with natural rodent pathogens, in vivo and in vitro studies of mucosal and smooth muscle function, primary cultures of immune cells, and molecular and immunohistochemical analyses. These studies will help us to understand how the host exploits physiological mechanisms in its defense against pathogens that allow for the stereotypic functional responses that promote expulsion. The impact of these studies is evident in that dysregulation of these functional changes significantly impairs host resistance and the maintenance of adequate barrier function and nutrient absorption. These studies also will provide insight on the mechanisms involved in the ability of nematode infection to protect against the development of autoimmune diseases, many of which are characterized by impaired intestinal barrier function. Project Narrative The rising prevalence of IBD is mirrored by the decreasing incidence of helminth infection, suggesting a relationship between the epidemiology of these diseases based, in part, on the polarity of Th cell responses. As one of the major regulatory mechanisms in the immune system is control of the balance of cytokines, both enteric infection and IBD are considered excellent targets for immunomodulatory therapies. Some nematodes induce an elevation of Th2 cytokines, including IL-4 and IL-13, which are linked to protective immunity against worm infection. Although a current therapeutic target in IBD is reduction of Th1 cytokine activity, an alternate approach is to rectify the Th1/Th2 cytokine imbalance by increasing Th2 cytokines. The recent clinical success of therapies directed at targeting Th2 cytokines provides a more specific therapeutic approach to the treatment of IBD than that offered by the standard anti-inflammatory and anti-immune regimens. Infection- induced up-regulation of Th2 and Th1 cytokines have a significant impact on gut function that is important to host resistance. The significance of the proposed studies is that they address how immune and structural cells interact to regulate gut function. The impact of these studies is based on identification potential therapeutic targets of benefit to pathologies associated with dysregulation of Th1 or Th2 responses.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel Cytokine Regulation of Gut Function and Inflammation
  • 批准号:
    8448748
  • 项目类别:
  • 资助金额:
    $24.83万
  • 财政年份:
    2009
  • 负责人:
    Terez Shea-Donohue
  • 依托单位:
Novel Therapy for Post-Irradiation Insult to Gut Mucosa in Non-Human Primates
  • 批准号:
    7875727
  • 项目类别:
  • 资助金额:
    $22.19万
  • 财政年份:
    2009
  • 负责人:
    Terez Shea-Donohue
  • 依托单位:
Novel Therapy for Post-Irradiation Insult to Gut Mucosa in Non-Human Primates
  • 批准号:
    7472916
  • 项目类别:
  • 资助金额:
    $75.0万
  • 财政年份:
    2007
  • 负责人:
    Terez Shea-Donohue
  • 依托单位:
GI Nematodes and Gut Functional Responses to Inflammation
  • 批准号:
    7388488
  • 项目类别:
  • 资助金额:
    $37.5万
  • 财政年份:
    2002
  • 负责人:
    Terez Shea-Donohue
  • 依托单位:
海外基金